Radiation Therapy Plus Paclitaxel and Cisplatin in Treating Patients With Cervical Cancer

Completed · Phase 1/Phase 2

Conditions studied: Cervical Cancer

In brief

RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Paclitaxel and cisplatin may increase the effectiveness of radiation therapy by making the tumor cells more sensitive to radiation. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining radiation therapy with chemotherapy may kill more tumor cells. PURPOSE: Phase I/II trial to study the effectiveness of radiation therapy to the pelvis plus paclitaxel and cisplatin in treating patients who have cervical cancer.

Key facts

Study ID
NCT00003379
Run by
Gynecologic Oncology Group
People needed
40
Starts
1999-11-01
Last updated by the study team
2013-05-27

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.